Limited Cell-Autonomous Anticancer Mechanisms in Long-Lived Bats

Fathima Athar,Zhizhong Zheng,Sebastien Riquier,Max Zacher,Dominic Alcock,Alex Galazyuk,Lisa Noelle Cooper,Tony Schountz,Lin-Fa Wang,Emma C. Teeling,Andrei Seluanov,Vera Gorbunova
DOI: https://doi.org/10.1101/2024.02.29.582714
2024-02-29
Abstract:Bats are remarkably long-lived for their size with many species living more than 20-40 years, suggesting that they possess efficient anti-aging and anti-cancer defenses. Here we investigated requirements for malignant transformation in primary bat fibroblasts in four bat species - little brown bat ( , big brown bat ( ), cave nectar bat ( ) and Jamaican fruit bat ( ) – spanning the bat evolutionary tree and including the longest-lived genera. We show that bat fibroblasts do not undergo replicative senescence and express active telomerase. Bat cells displayed attenuated stress induced premature senescence with a dampened secretory phenotype. Unexpectedly, we discovered that bat cells could be readily transformed by only two oncogenic perturbations or “hits”: inactivation of either p53 or pRb and activation of oncogenic RASV12. This was surprising because other long-lived mammalian species require up to five hits for malignant transformation. Additionally, bat fibroblasts exhibited increased p53 and MDM2 transcript levels, and elevated p53-dependent apoptosis. The little brown bat showed a genomic duplication of the p53 gene. We hypothesize that bats evolved enhanced p53 activity through gene duplications and transcriptional upregulation as an additional anti-cancer strategy, similar to elephants. In summary, active telomerase and the small number of oncogenic hits sufficient to malignantly transform bat cells suggest that bats rely heavily on non-cell autonomous mechanisms of tumor suppression.
Cell Biology
What problem does this paper attempt to address?